First-line therapy with temozolomide induces regression of primary CNS lymphoma

Neurology. 2002 May 28;58(10):1573-4. doi: 10.1212/wnl.58.10.1573.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents, Alkylating / therapeutic use*
  • Central Nervous System Neoplasms / drug therapy*
  • Central Nervous System Neoplasms / pathology
  • Dacarbazine / analogs & derivatives
  • Dacarbazine / therapeutic use*
  • Female
  • Humans
  • Lymphoma / drug therapy*
  • Lymphoma / pathology
  • Male
  • Middle Aged
  • Temozolomide

Substances

  • Antineoplastic Agents, Alkylating
  • Dacarbazine
  • Temozolomide